Loading…
Corline Biomedical has signed a non-exclusive license and supply agreement with Canadian company Kardium to use Corline's CHS antithrombotic coating on ablation catheters. The deal includes royalties, ongoing purchases, and an annual fixed fee.
“Avtalet är icke-exklusivt och ger Kardium rätten att använda CHS™- teknologin för ablationsprodukter på samtliga marknader i världen.”globenewswire.com
Summarized from public sources; check the original articles before acting on it.